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4 Abstract 

In the present study, a formerly designed Dynamic Micro Tissue Engineering 
System (DynaMiTES) was applied with our prevalidated human hemicornea (HC) 
construct to obtain a test platform for improved absorption studies of the anterior 
eye (Ocular DynaMiTES). First, the cultivation procedure of the classic HC was 
slightly adapted to the novel DynaMiTES design. The obtained inverted HC was then 
compared to classic HC regarding cell morphology using light and scanning electron 
microscopy, cell viability using MTT dye reaction and epithelial barrier properties 
observing transepithelial electrical resistance and apparent permeation coefficient of 
sodium fluorescein. These tested cell criteria were similar. In addition, the effects of 	
four different flow rates on the same cell characteristics were investigated using the 

DynaMiTES. Because no harmful potential of flow was found, dynamic absorption 
studies of sodium fluorescein with and without 0.005 %, 0.01 % and 0.02 % 
benzalkonium chloride were performed compared to the common static test 
procedure. In this proof-of-concept study, the dynamic test conditions showed 
different results than the static test conditions with a better prediction of in vivo data. 
Thus, we propose that our DynaMiTES platform provides great opportunities for the 
improvement of common in vitro drug testing procedures. 
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6 Introduction 
The development of novel drugs or innovative formulations is both cost intensive and 
time consuming. Thus, much effort is spent in the early phases of this process to 
obtain reliable findings. Unfortunately, most common preclinical test systems are 
based on animal experiments, ex vivo or in vitro models utilizing cell cultures, which 
all have well-known disadvantages. For example, the application of animals is 
ethically questionable and rarely representative for the effect in humans [5,21,40]. 
Furthermore, ex vivo as well as in vitro experiments are usually performed under 
static conditions, which cannot adequately mimic the physiological conditions in 	
humans. Consequently, misleading outcomes often result in late stage drug failure. 

For this reason, scientists have been working for decades on improved in vitro 
methods for the early and reliable selection of the most important and promising drug 
candidates. One tremendous innovation in this field was the development of organ on 
chip (OOC) systems in the early 2010s [3,22,55]. In these microstructured systems, 
well-characterized cell cultures can be cultured within small dimensions under a 
highly controlled microenvironment. These features should ease the in vitro 
emulation of human physiology and may ultimately lead to more reliable 
results [5,10,32,49].  
Despite great hope, OOC systems also exhibit essential disadvantages. On the one 	
hand, they are poorly compatible with well-known cell culture systems. Thus, cell 

culture laboratories, which have long-term experience with in vitro models, cannot 
easily adapt them to OOC systems. Consequently, new efforts must be made to this 
purpose. Other dynamic systems, which enable the integration of standard cell 
culture models, such as the Quasi Vivo® system (Kirkstall, Rotherham, UK), do not 
provide additional analysis, such as continuous transepithelial electrical 
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resistance (TEER) measurement [26], as OOCs try to include [6]. On the other hand, 
the most commonly used material for OOC fabrication, polydimethylsiloxane (PDMS), 
is known for its intensive substance absorption [39,45]. In research, it is used due to 
its easy structurability even with challenging geometries, its transparency, its 	
biocompatibility and its gas permeability. However, substance absorption can hinder 

cell nutrition and, more importantly, the detection of drugs. For these reasons, PDMS 
is not an ideal material for routinely used absorption test systems of strong 
physiological and poorly permeated barriers, such as the human cornea. 
Against this background, our interdisciplinary team of engineers and pharmacists has 
developed a microstructured system for dynamic in vitro drug absorption tests that 
circumvents these disadvantages and allows the integration of standard cell culture 
inserts and includes continuous TEER measurement. The resulting Dynamic Micro 
Tissue Engineering System (DynaMiTES; see Figure 1) was built for dynamic cell 
cultivation and, more importantly, the dynamic drug absorption testing on 	
physiological barriers. 

One pharmaceutically challenging physiological barrier is the human cornea. Ocular 	
drug absorption is hindered to a great extent due to very tight cell-cell connections 	
and short precorneal residence time because of tear flow [4,23]. Unfortunately, 	
common ocular test systems apply static test conditions and thus fail to reliably 	
emulate the dynamic human physiology. Consequently, the harmful effects of 	
excipients, such as preservatives, might have a stronger effect on the permeated 	
drug amount than in the clinical application. As no dynamic setup for cell culture 	
models has been reported to date, an Ocular DynaMiTES for the implementation of 	
in vivo-like conditions in pharmaceutical formulation testing would be the first step 		
toward significantly improving the common test practice. Unlike static test systems, 	

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the enhanced dynamic system might not overestimate increased drug absorption 

resulting from non-physiological harmful conditions or toxic effects. For this reason, a 

dynamic test procedure will ensure an improved emulation of the in vivo situation and 

may offer a significant contribution to more reliable preclinical in vitro test 

systems [37]. 

For the generation of an Ocular DynaMiTES, our well-characterized and prevalidated 

human hemicornea (HC) construct [19,20] was applied within the DynaMiTES. In our 

first study, the technical design was tested and simulated intensively. Furthermore, 

the cell compatibility of all applied materials was investigated (see PART 1). Based 
	
on these findings, our second study (PART 2) focused on the cellular component - 


the HC construct. First, the cultivation of the HC had to be slightly adapted due to the 
DynaMiTES design. The resulting inverted HC was then compared to the classic HC 
with regard to cell morphology, cell viability, TEER value and apparent permeation 
coefficient (Papp) of sodium fluorescein as a paracellular marker substance to ensure 
similar cell characteristics. Second, absorption studies with sodium fluorescein were 
performed within the DynaMiTES with and without flow conditions. In this manner, 
potential harming or biasing effects of the materials and the engineering design could 
be examined. For this reason, four different flow rates were tested concerning cell 
viability, cell morphology, TEER value and Papp. After successfully performing this 	
stepwise alteration of the common static in vitro practice, the first donor dilution 

experiments with and without a common ocular permeation enhancing preservative, 
benzalkonium chloride (0.005 %, 0.01 % and 0.02 %) [9,24,41], were performed to 
demonstrate the benefits of our dynamic test system. Taken together, these studies 
should show the importance and readiness of the Ocular DynaMiTES for application 
in improved drug absorption studies of the anterior eye. 
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7 Materials and Methods 
7.1 Materials 
Cell culture flasks and Transwell® inserts (art. no. 3402) were purchased from 
Sarstedt (Nümbrecht, Germany) and Corning Costar (Kennebunk, Maine, US), 	
respectively. The Keratinocyte Growth Medium (KGM), which emerged from the 

Keratinocyte Basal Medium (KBM) by the addition of SingleQuots®, was provided 
from Lonza (Basel, Switzerland). KCl and MgSO4 × 7 H2O were acquired from Acros 
Organics (Geel, Belgium). Phosphate Buffered Saline (PBS) tablets and EDTA 
disodium salt solution were obtained from MP Biomedicals (Santa Ana, California, 
US). Trypsin-EDTA and trypsin inhibitor were acquired from Thermo Fisher 
Scientific (Waltham, Massachusetts, US). The acetic acid, NaCl, NaHCO3, HEPES, 
ascorbic acid, D-glucose monohydrate, CaCl2 × 2 H2O, sodium dodecyl 
sulfate (SDS), formaldehyde 4 % solution, glutaraldehyd 25 % solution, 
osmiumtetroxid 2 % solution and hematoxylin solution were purchased from Carl 	
Roth (Karlsruhe, Germany). Technovit 7100 was obtained from Heraeus 

Kulzer (Wehrheim, Germany). The NaH2PO4 × H2O and the L-glutamine were 
provided by Merck (Darmstadt, Germany). Sodium fluorescein, hydrochloric acid, 
10-fold MEM and 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium 
bromide (MTT) were purchased from Sigma-Aldrich (Munich, Germany). 
Benzalkonium chloride (BAC) 50 % solution was purchased from Caelo (Hilden, 
Germany). The PCR mycoplasma test kit for routinely mycoplasma screening was 
bought from Promocell (Heidelberg, Germany). The collagen for the three-
dimensional gel was extracted from rat tail following a standard protocol. The 
employed Krebs-Ringer buffer (KRB) contained 6.8 g NaCl, 0.4 g KCl, 0.14 g 	
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NaH2PO4 × H2O, 2.1 g NaHCO3, 3.575 g HEPES, 1.1 g D-glucose monohydrate, 

0.2 g MgSO4 x 7 H2O and 0.26 g CaCl2 × 2 H2O in 1000 mL of double-distilled water. 
7.2 Cultivation of Human Corneal Epithelial (HCE-T) Cells  
The HCE-T cell line originated from a 49-year-old female and was immortalized by 
transfection with a recombinant SV40-adenovirus vector. This establishment and the 
subsequent characterization were performed by Araki-Sasaki et al. [2]. The HCE-T 
cells for the following study were purchased from the RIKEN cell bank (Tsukuba, 
Japan) and cultured with KGM at 37 °C and 5 % CO2 in a humidified atmosphere. 
7.3 Cultivation of Human Corneal Keratocytes (HCK) Cells 
The HCK cell line was also immortalized by transfection with an SV40-adenovirus 	
vector but derived from human corneal keratocytes [20,57]. For the cultivation of our 

HC, HCK cells were provided by Dr. M. Zorn-Kruppa (Hamburg, Germany) and 
cultured with KGM under the same conditions as HCE-T cells.  
Both cell types were routinely tested for mycoplasma infection. 
7.4 Cultivation of Human Hemicornea (HC) Construct  
For the combination of our well-known HC construct and novel DynaMiTES as an 
Ocular DynaMiTES, the cultivation of HC was slightly adapted. Due to the insert 
orientation within the DynaMiTES (see Figure 2) and to ensure fluid flow over the 
corneal epithelium, HCE-T cells were grown on the bottom side of the insert 
membrane. For this reason, the HC for the DynaMiTES was cultured inversely in 	
contrast to the classic culture conditions of Hahne et al. [19,20] (see Figure 3). 

For the classic HC, HCK cells within a collagen stroma matrix and HCE-T cell lines 
placed on top of the HCK cells were cultured with KGM under serum-free conditions 
on permeable polycarbonate Transwell® filters at 37 °C and 5 % CO2 in a humidified 
https://doi.org/10.24355/dbbs.084-201904011253-0
	

atmosphere as described by Hahne et al. [19,20]. For the inverted HC, the collagen 
gel production was identical to the classic HC but different from the classic cultivation 
the Transwell® inserts were placed upside down into a 6-well plate after the gelling 
process. A HCE-T cell suspension of 100,000 cells/200 µL was then applied to the 
bottom surface of every insert. After cell adhesion for 1 h, 3 h or overnight (18 h), the 
inserts were reversed and cultured until day 7 similar to the classic HC protocol. On 	
day 7, all HCs were lifted to an air-liquid interface to induce an epithelial multilayer. 

The inverted HCs were once more inverted to the 6-well plate and fed daily with KGM 
from underneath the insert. For optimal cell nutrition, the inserts were always 
carefully tilted to avoid air accumulation under the collagen gel.  
7.5 Technical Design of the DynaMiTES 
As the technical component of our ocular system, the DynaMiTES consist of three 
separate levels: bottom level, insert level and top level (see Figure 1; for technical 
development and fabrication see PART 1). All these levels are built from 
polycarbonate (PC). Because the DynaMiTES was designed for repeated use, unlike 
common OOCs, the PC fabrication ensures enhanced durability and low substance 	
absorption [51]. Furthermore, the modular design with its three levels enables 

individualization for a wide range of cell culture laboratories and their in vitro models. 	
For example, the insert level can be adapted to different insert geometries, whereas 	
the top and bottom levels, which are more elaborate to produce, can remain 	
unchanged. The customizable insert level also consists of a sampling point to access 	
the acceptor, which is situated between the insert and bottom levels. Acceptor and 	
donor volumes were designed similar to common in vitro tests, at 1600 µL and 	
370 µL, respectively. Furthermore, the microstructured donor channel with its posts 	
ensures optimal mixing conditions (for channel construction and flow simulation see 	
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PART 1). However, this design is the opposite of the common test procedure, where 		
the donor is applied in the insert and the acceptor is provided beneath the insert (see 	

Figure 2 and Figure 6). This change was important to ensure in vivo-like fluid flow 

across the cellular surface. Additionally, it eases dynamic donor variation, such as 

donor dilution, mimicking physiological concentration gradients. Moreover, it allows 

further downsizing of the channel dimensions for subsequent improvements to even 

closer emulate human physiology. In addition to donor variation, TEER electrodes 

built from stainless steel were included in the top and bottom levels. These additions 

allow continuous TEER measurement and provide real-time information of the 

substance-barrier interaction. 

After successfully testing the cell compatibility (see PART 1) and cell characteristics 
	
of the inverted HC (see Section 8.1), flow conditions were simulated using the 


DynaMiTES. A basal flow rate (31 µL/min) and an initial flow rate (73 µL/min), 
whereby the latter emulates the increased tear flow after instillation, were chosen 
following Sörensen and Taagehöj [43] and calculated for the donor volume of 
370 µL (see PART 1). In addition, a slightly elevated flow rate (93 µL/min) and 
doubled initial flow rate (148 µL/min) were applied to investigate method limits. The 
effect of these flow rates on cell morphology, cell viability, TEER and Papp was 
investigated using the following methods. As a negative control, inverted HC in the 
standard well plate (0 µL/min well plate) and in the DynaMiTES without 
flow (0 µL/min DynaMiTES) were investigated in parallel.  	
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7.6 Cell Morphology 

7.6.1 Light Microscopy (LM) 
For light microscopic observation of tissue cross sections using an Olympus IX50 
photomicroscope (Olympus, Hamburg, Germany), the HCs were fixed with a 
phosphate buffered solution of 4 % formaldehyde for 24 h and subsequently 
dehydrated with an ethanol series. Next, the HCs were cut into two halves, and each 
half was embedded in a plastic resin on a base of hydroxyethylmethylacrylate 
(Technovit 7100) according to the manufacturer’s protocol. This resin block was cut 
in 3.5-µm-thick slices, which were stained using hematoxylin and eosin. 
7.6.2 Scanning Electron Microscopy (SEM) 	
For electron microscopic observation of the epithelial surface area using LEO 

1550 (Zeiss, Oberkochen, Germany), the HCs were fixed with a 4 % solution of 
glutaraldehyde for 90 min and post-fixed with a 2 % solution of osmium tetroxide for 
2 h. Subsequently, the tissue was dehydrated employing an ethanol series and 
air-dried overnight. After this drying process, the Transwell® membrane was 
immobilized on an SEM sample holder, and the epithelial surface was coated with 
gold using Bal-Tec SCD 050 (Balzer, Wiesbaden, Germany). 
For the morphological evaluation of flow effects, inverted HCs in the standard well 
plate (0 µL/min well plate) and in the DynaMiTES without flow (0 µL/min DynaMiTES) 
served as a negative control. In contrast, inverted HCs whose epithelium was 	
scratched with a glass pipette were treated equally as a positive reference. 

7.7 Cell Viability 
Cell viability was investigated by using an MTT dye reaction. For this purpose, the 
apical and basolateral side of the HC were exposed to a 1+4 mixture of MTT stock 
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solution (5 mg/mL) and KGM. After three hours of reaction at 37 °C, 5 % CO2 and 
humidified atmosphere, the MTT solution was removed. For cell lysis, a lysis solution 
containing 2.73 g SDS, 3.64 g hydrochloric acid, 88.18 g water and 905.45 g 
isopropanol was applied to both sides of the HC and incubated overnight. Next, an 
aliquot was diluted 1+3 with fresh lysis solution, and absorption was measured at 
570 nm using an UV-VIS plate reader Powerwave XS from BioTek (Winooski, 	
Vermont, US). On the basis of these results, cell viability was calculated in 

relationship to an untreated reference in a well plate. 
To investigate the effect of flow, the inverted HCs were set into the DynaMiTES insert 
level. Next, different flow rates of KRB were applied for the intended experimental 
duration of three hours. Cell viability was then assessed as previously described. 
7.8 Transepithelial Electrical Resistance 
TEER measurement during cultivation, as well as prior to and during the absorption 
studies, was performed using EVOM® combined with Endohm® Chamber from World 
Precision Instruments (WPI, Sarasota, Florida, US). For TEER measurement within 
the DynaMiTES, the incorporated electrodes were connected to the EVOM®, and 	
TEER was measured on every sampling point of the absorption study. For the TEER 

profiles, the starting TEER value of every HC was set as 100 %, and the subsequent 
values were calculated in relationship to the starting value. 
As a negative control, the TEER profiles of inverted HCs in a normal well plate were 
assessed simultaneously for each experiment. Biasing effects on the TEER 
measurement resulting from the DynaMiTES construction or the flow itself were 
investigated with a positive control. For this reason, inverted HCs were devitalized 
with a solution of 0.03 % SDS over 3 h prior to the experiment. Subsequently, the 
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TEER profiles were analyzed over 180 min with a flow rate of 31 µL/min. Because no 
base line shift was observed, biasing effects of the DynaMiTES cannot be 	
expected (data not shown). 

7.9 Static Absorption Studies  
In addition to TEER, the absorption of sodium fluorescein as a hydrophilic and 
paracellular marker substance [31] was used for the evaluation of epithelial barrier 
properties. All absorption studies were performed in KRB according to the 
prevalidation study of the classic HC [20]. The donor solution (250 µg/mL sodium 
fluorescein in KRB) was applied to the epithelial surface at day 10 of cultivation (see 
Figure 6A), and the amount of permeated sodium fluorescein in the acceptor 
compartment was detected over the course of 180 min. All acceptor samples were 
analyzed using a fluorescence microplate reader Genios from Tecan (Männedorf, 	
Switzerland) at an excitation wavelength of 485 nm and an emission wavelength of 

535 nm. From the obtained concentrations, the amount of permeated sodium 
fluorescein was calculated and plotted over time. The linear ascent of these 
permeation profiles was then used to calculate the apparent permeation 
coefficient (Papp) as described by Hahne et al. [20]. 
For absorption studies within the DynaMiTES, the inlet of every system was 
connected with a syringe pump (KDS 270 Legacy Syringe Pump, KD Scientific, 
Holliston, Massachusetts, US). The donor compartment was then either filled once 
with the donor solution (250 µg/mL sodium fluorescein) for the simulation of classic 
static test conditions or the donor was pumped along the epithelial surface with four 	
different flow rates for flow effect investigation (see Figure 2 and Section 7.5). 

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7.10 Static vs. Dynamic Absorption Studies  	
The dynamic absorption studies were performed with a 10-fold higher concentration 	
of sodium fluorescein (2.5 mg/mL) to ensure acceptor concentration above the 	
detection limit. After a single donor filling (bolus application), an initial flow rate of 	
KRB (73 µL/min) was applied for 5 min to simulate elevated tear drainage after 	
instillation [33,43]. Subsequently, a basal flow of KRB (31 µL/min) was applied for 	
175 min. Acceptor samples were obtained and analyzed similar to the static 	
absorption studies. In parallel, static experiments without KRB dilution were 	
performed in the DynaMiTES with the same donor solution. 		
As a proof-of-concept, the comparison of static and dynamic test conditions was 	

further performed after exposure to 0.005 %, 0.01 % and 0.02 % BAC in KRB. To 

avoid BAC and sodium fluorescein interaction, both substances were applied 

consecutively. In the first phase, the HC was exposed to a specific BAC solution. For 

dynamic exposure, BAC was diluted by KRB flow (5 min 73 µL/min and 25 min 

31 µL/min) after a bolus application. A second flow regime with 10 min of 73 µL/min 

and 20 min of 31 µL/min was tested with the highest BAC concentration to 

investigate the flow rate effect(0.02 % EF = elevated flow). In static experiments, the 

donor remained unchanged for 30 min. In the second phase, the sodium fluorescein 

permeation was performed similar to the dynamic absorption studies over the course 
	
of 180 min. Dynamic BAC exposure was always followed by dynamic sodium 


fluorescein permeation to simulate the novel dynamic test conditions. In contrast, 
static BAC exposition was followed by static sodium fluorescein permeation to 
recreate common static test procedures. For the latter, the Papp was calculated from 
the linear ascent as previously described (see Section 7.9). In the dynamic 
experiments, this was not feasible due to the lack of infinite dose. Thus, the acceptor 
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concentrations of sodium fluorescein were utilized for a comparison of the dynamic 
conditions.  
7.11 Statistical Analysis 
Statistical analysis was performed using IBM SPSS Statistics 24 (IBM, Armonk, New 	
York, US). Differences between two groups were compared using independent two-

sample t-test. More than two groups were investigated using one-way 
ANOVA (analysis of variance). For detailed distinction, of differences found in 
ANOVA the Bonferroni post hoc test was used for homogeneous variance and the 
Games-Howell post hoc test for inhomogeneous variances. p-values of less than 
0.05 were considered significant (p < 0.05*, p < 0.01**).  
8 Results 
8.1 Adaption of HC Cultivation to the DynaMiTES Design 
As previously discussed, the HC cultivation was adapted for the application of the HC 
construct within the DynaMiTES. The resulting inverted HC were then compared to 	
the classic HC with regard to cell morphology, cell viability, TEER and Papp to ensure 

similar cell characteristics. 
8.1.1 Cell Morphology 
A variation in attachment time (1 h, 3 h und 18 h) for the epithelial cells of the 
inverted HC displayed an increasing number of epithelial layers with increasing 
attachment time (see Table 1). However, morphology similar to the classic HC was 
best obtained with overnight attachment. Classic as well as inverted HC showed both 
tight epithelial cell growth with two to more cell layers under these conditions (see 
Figure 3). Thus, overnight attachment was used for all following experiments. 
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8.1.2 Cell Viability 	
Cell viability of classic and inverted HC were compared using MTT dye reaction. As a 

positive reference, a group of stroma equivalents without HCE-T cells and only 
containing HCK cells was cultured simultaneously. On day 10 of cultivation, classic 
as well as inverted HC showed cell viabilities of or close to 100 %, which were not 
significantly different from each other. In contrast, the cell viability of the positive 
reference was significantly diminished, caused by HCE-T cell exclusion (see 
Figure 4). 
8.1.3 Transepithelial Electrical Resistance 
In addition to cell morphology and cell viability, TEER values were measured on 
cultivation day 6, the day before ALI (see Figure 3), and until day 13. In this manner, 	
changes in the epithelial barrier resulting from the ALI cultivation could be 

investigated over an extended period of eight days (see Figure 5). Within this time 
span, the classic HC showed higher TEER values at the beginning, which decreased 
constantly during ALI cultivation. In contrast, the inverted HC showed decreasing 
TEER values, which increased after the beginning of ALI cultivation. Despite these 
differing TEER developments in the early phases of cultivation, classic as well as 
inverted HC showed similar TEER values on day 10, the day of application for 
absorption studies following Hahne et al. [20]. An extended cultivation did not show 
any significantly different TEER values for the following three days. A TEER optimum 
was reached between day 10 and day 11 for the inverted HC, which was similar to 	
the findings observed by Hahne and Reichl for classic HC in 2011 [19]. 

8.1.4 Absorption Studies 
Following the absorption studies of Hahne et al. [19,20], the Papp of sodium 
fluorescein was analyzed on day 10 of cultivation for the inverted as well as for the 
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classic HC. As the similar TEER values might have indicated, the obtained Papp 
values were also not significantly different between both groups. Moreover, the 
values were similar to the values for the classic HC published by 
Hahne et al. [20] (see Figure 6). 
8.2 Absorption Studies with and without Flow in the DynaMiTES 
After successfully adapting the HC’s cultivation for the novel design, the potential 	
harmful effects of fluid flow should be investigated prior to the application of dynamic 

experimental test conditions. For this reason, cell morphology, cell viability, TEER 
and Papp of the inverted HC were analyzed with and without utilizing different flow 
rates. 
8.2.1 Cell Morphology  
Cell morphology was observed using LM for the investigation of cell abrasion or 
alterations in cell layer formation. Furthermore, SEM was used for an extensive 
observation of the epithelial surface to detect randomly occurring changes in the 
epithelium. 
In LM, neither cell detachment nor hole formation as a consequence of the applied 	
fluid flows were observed (see Table 2; left column). All images showed a 

multilayered epithelium with a more or less uneven surface, which may have resulted 
from the loss of contact inhibition as previously demonstrated for other SV-40 
immortalized cell lines [30,44] or the fact that in contrast to the in vivo situation all cell 
layers are proliferating. Furthermore, the lack of lid movement and desquamation 
may have caused a less smooth and compact surface. However, all appearances in 
the DynaMiTES regardless of flow were similar to the negative control in the well 
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plate. Moreover, a clear scratch in the deliberately injured positive control was visible 
and demonstrated that changes in cell morphology would be detectable. 
In the SEM images, a similar observation could be obtained (see Table 2, right 	
column). The samples with and without flow from the DynaMiTES showed no hole 

formation, as no PC membrane was visible in any of the samples areas. However, an 	
intended injury, and thus the underlying PC membrane were clearly visible in the 	
positive control. By locating the injury close to the margins, we were able to 	
demonstrate that it is possible to detect mechanical injuries close to the insert edges 	
using SEM imaging. Regarding the cellular surface, uneven cell areas were observed 	
similar to the LM images. Overall, only a slight tendency toward a more defined 	
surface structure could be observed with an increasing flow rate. The irregular 	
surface in the image of the flow rate (93 µL/min), which was not observed in other 	
samples, may be caused from the sample preparation. 		
8.2.2 Cell Viability 	

In addition to cell morphology, cell viability was examined after three hours of flow 

exposition. Because this was the expected experimental time for subsequent drug 

absorption studies, cell viability should not be restricted by shear stress or other 

effects during this period. A negative control was maintained in KRB in a standard 

well plate. Furthermore, a group of inverted HCs were inserted into the DynaMiTES, 

and no flow was applied (0 µL/min). The results in Figure 7 underline that no clear 

reduction in cell viability was found as all groups showed values above 90 % 

regardless of the tested flow rate. 

8.2.3 Transepithelial Electrical Resistance 
	
The integrated TEER electrodes of the DynaMiTES were used to investigate TEER 


development over the experimental time of 180 min. Thus, the relative TEER value 
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was obtained with and without flow over the course of 180 min (see Figure 8). As a 
negative control, the TEER development of inverted HCs in a cell culture well plate 
was analyzed simultaneously for every batch. 
When comparing the inverted HCs, a slight but constant decreasing trend could be 
observed in the negative control. Resulting from this decrease, all groups from the 
DynaMiTES (except 73 µL/min) were significantly different to 0 µL/min well 
plate (p < 0.05) after 180 min but not to 0 µL/min DynaMiTES. Furthermore, a flow 
rate of 73 µL/min showed a short decrease in TEER value within the first 10 min and 	
a stable value afterwards. All other flow rates initially showed ascending and 

subsequently stable TEER profiles. From these flow rates, the inverted HCs, which 
were exposed to 93 µL/min, showed the highest relative TEER value.  
8.2.4 Absorption Studies  
As a second parameter for the evaluation of epithelial barrier properties, the Papp of 
sodium fluorescein was accessed in the DynaMiTES with and without the application 
of different flow rates. As a negative control, an absorption study in a well plate was 
performed simultaneously in every experiment. The obtained Papp values are shown 
in Figure 9. The inverted HCs from the DynaMiTES showed all and, regardless of the 
flow no significant increase in Papp compared to the reference in the well plate. Only 	
an injury, resulting from a static exposition to 0.01 % BAC, had significantly increased 

the determined Papp. 
8.3 Dynamic Absorption Studies in the DynaMiTES 
After the investigation of all harmful or interfering effects, the DynaMiTES was utilized 
for a small proof-of-concept study. Because, the system should emulate physiological 
tear drainage and thus enable the reliable evaluation of ocular drug absorption at the 
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anterior eye, the effect of divers benzalkonium chloride concentrations were 
investigated under static and dynamic experimental conditions. 
8.3.1 Static vs. Dynamic Absorption Studies  
The obtained results (see Figure 10) for sodium fluorescein without BAC addition 	
showed a typical linear concentration-time curve for the static test conditions after 

reaching a steady state. In contrast, dynamic test conditions showed a lower curve, 
which flattened until the end of the experiment. 
Following exposure to 0.005 % BAC, the curves for both conditions were similar to 
the curves without BAC. For the concentration of 0.01 % BAC, an increase in 
permeability (Papp) could only be detected for the static procedure 
(2.83 × 10-7 ± 0.09 × 10-7 cm/s without BAC vs. 12.2 × 10-7 ± 6.91 × 10-7 cm/s for 
0.01 % BAC - 4.3-fold increase in Papp), whereas no increase was found under 
dynamic conditions. When applying 0.02 % BAC, the curves for static 
(12.6 × 10-7 ± 2.09 × 10-7 cm/s - 4.5-fold increase in Papp) and dynamic conditions 	
(10.3-fold increase in concentration) were both increased compared to the curves 

without BAC. Furthermore, the static curves for 0.01 % and 0.02 % BAC were 
comparable and showed no further increase in sodium fluorescein concentration with 
increasing BAC concentration. In contrast to the other curves, the two conditions both 
showed dramatically shortened lag phases in the beginning and had flattened over 
the entire experimental time. 
However, the increase in dynamic concentration profile could not be observed for 
0.02 % BAC with the second flow regime involving an extended initial flow rate phase 
(1.6-fold increase in concentration with 0.02 % BAC EF = elevated flow). 
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9 Discussion 	
9.1 Adaption of HC Cultivation  

The four cell characteristics, morphology, viability, TEER and Papp, which were 
observed in this study together indicated that an alteration in the cultivation 
procedure did not significantly affect the tested criteria of our HC. The HCE-T cells on 
the bottom surface of the membrane developed an epithelium with 2-4 cell layers, 
suggesting similar epithelial barrier properties (TEER and Papp). Other inverted 
cultivations without prior coating have been previously described for Calu-3 cells and 
MDCK II cells in a lung model [7] and kidney model [56], respectively. However, to 
the best of our knowledge, cultivation on the bottom surface of the insert has not yet 
been reported for corneal cells, specifically HCE-T. A slightly different inverted 	
cultivation has been published by Zorn-Kruppa et al. [57]. However, their cultivation 

of HCE-T cells within the insert does not allow direct flow exposition to the 
epithelium. For this reason our inverted cultivation is more suitable for the intended in 
vivo-like conditions within the DynaMiTES. 
Furthermore, in the study of Bur et al., the cells were left to adhere for 48 h [7], which 
is longer than in our protocol, although a larger medium volume of 500 µL (compared 
to 200 µL) was used. To apply this larger volume, tubes were placed over the insert. 
Advantageously, these tubes, which may harm the cell layer when removed, were 
avoided in our protocol. Moreover, our overnight adhesion was longer than the 5-h 
time period examined in the study of Wakabayashi et al. [56]. Nevertheless, no 	
harming effects were detected in the MTT test, as the initial seeding volume of 

200 µL was higher than the 100 µL in the study of Wakabayashi et al. and our 
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collagen gel was generated using 10-fold MEM and thus ensured cell nutrition until 
the next day. 
Morphologic observations demonstrated that the two cell types could grow in physical 
proximity. The cells might interact even through the PC membrane as the pore size 
of 3 µm is much wider than the molecule size of cytokines and other signal 
molecules. For this reason, the benefit of co-cultivation remains unchanged and, 
thus, other cell characteristics, such as substance transport [52–54] and substance 
metabolism [27,28], which we investigated extensively in our former studies, might 	
also be maintained. This finding was also supported by the cell viability results. 

Classic and inverted HC showed both similar values. Only the value of the stromal 	
equivalents was higher than it might be estimated by the initial cell seeding 	
density [19]. However, this may result from a higher metabolic activity of the HCK 	
cells compared to the HCE-T cells.  	
With regard to the TEER observation, the differences in the early TEER development 	
between classic and inverted HC are of minor interest, as all models were not used 	
until day 10 of cultivation and upon completed formation of the epithelial multilayer. 	
Furthermore, the late TEER values, including the TEER optimum from day 10 to 	
day 11 as well as the Papp values were comparable between all groups and similar to 		
the values reported in previous studies [19,20]. 	

9.2 Absorption Studies with and without Flow in the DynaMiTES 

Morphological investigation with and without flow did not result in cell detachment or 

hole formation in the epithelium. Because we were able to detect injuries close to the 

margins using SEM imaging, we could also conclude that insertion of our in vitro 

model into the DynaMiTES did not cause any damage. This assumption was 

https://doi.org/10.24355/dbbs.084-201904011253-0


supported by other previous results. Extensive detachment of the cells would have 

decreased the obtained cell viability as previously demonstrated for stromal 

equivalents (see Figure 4 and Figure 7). Moreover, regardless of flow exposure, no 

significant decrease in TEER or increase in Papp values occurred in the DynaMiTES. 
	
Thus, no negative effects of the flow were expected. Nevertheless, the flow rates of 


the current study were relatively low. Consequently, the shear 
stresses (1.72 × 10-4 Pa for 148 µL/min; for shear stress calculation see PART 1) 
were much lower compared to the in vivo conditions (up to 15 Pa [15]). However, we 
only aimed to simulate tear drainage and thus did not intend to apply shear stress 
similar to physiological blinking forces. In the present work, the shear stresses and 
short exposure time resulted in slight changes in cell morphology or TEER, which 
might be extended with application of higher shear stresses and a prolongation of 
flow exposure. Stimulating or life extending effects of physiological flow have for 
example been reported for models of the human gut [25], liver and skin [50,55]. 	
Regarding monolayers of SV-40 immortalized corneal epithelial cell lines, 

Pretor et al. found no morphological changes with a shear stress of 0.1 Pa [38]. 
However, Utsunomiya et al. observed significantly decrease in wound healing and 
corneal cell proliferation after the exposition to 1.2 Pa [48]. For this reason, an effect 
of increased shear stress in drug absorption testing or specifically in dynamic 
cultivation for the inverted HC (see Section 10) should be further investigated in 
subsequent studies. 
In addition to the investigation of flow effects, we showed the reliability and benefit of 
the inbuilt TEER electrodes in real-time TEER assessment. Because standard 
measuring systems, such as EVOM2 combined with EndOhm® Chamber, only allow 	
TEER analysis before and after the absorption study without any disruption, no real-

https://doi.org/10.24355/dbbs.084-201904011253-0


time information with a time-dependent evaluation of substance barrier interactions is 
feasible. Alternative measurement systems, such as the EVOM2 with chopstick 
electrode (STX2 electrode, WPI, Sarasota, Florida, US), entail multiple error 
possibilities as variable electrode positions and cross-contamination of the tested 
substance. Fortunately, our DynaMiTES resolves all these challenges and enhances 
the informational content that is obtained in in vitro absorption studies. 
9.3 Dynamic Permeation Studies in the DynaMiTES 
In our first dynamic experiments without BAC, the novel and in vivo-like test 
procedure showed a reduced concentration profile compared to static conditions. 	
This finding resulted from shorter exposure time periods to sodium fluorescein in 

consequence of the simulated tear drainage. Moreover, the dynamic curve flattened 
over the permeation time due to of the diminishing concentration in the donor 
compartment and the consequently decreasing concentration gradient. This 
progression more resembled the physiological kinetics [13,42] than static conditions. 
In the latter, the high donor concentration generated a constant concentration 
gradient during the entire experimental time. As a result, higher acceptor 
concentrations and linear concentration-time curves were achieved under static 
conditions. Although, these findings enable further calculation of the Papp as a 
parameter for substance absorption, this profile progression cannot be easily 	
transferred to in vivo conditions [46]. 

Apart from the differences in static and dynamic experimental conditions, we 
investigated the effect of BAC. Because this substance is a common and frequently 
used preservative, many studies examining the effects of BAC have been previously 
performed. Among these studies, an increasing harmful potential with increasing 
concentration has been reported [11,18,36] and was also found in the present study. 
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For example, the lowest BAC concentration (0.005 %) showed neither an effect 
under static nor under dynamic conditions. The doubled concentration then caused a 
clear effect only under static conditions (4.3-fold increase in Papp), which could be 
marginally increased with a higher BAC concentration. For 0.02 % BAC, the Papp was 	
4.5-fold higher than the reference without BAC. In this case, the non-physiological 

static exposure time of 30 min may have resulted in an immense and maximum 
barrier-impairing effect for 0.01 % and 0.02 % BAC. Consequently, no further 
increase in permeability was observed with increasing concentration. Moreover, this 
large barrier disruption may have caused a dramatic reduction in lag time for sodium 
fluorescein permeation under these conditions. 
However, no increase in sodium fluorescein concentration was found for dynamic 
conditions lower than 0.02 % BAC. This high concentration then caused a 10.3-fold 
increase in acceptor concentration compared to dynamic conditions without BAC. No 
effect was found below 0.02 % BAC, which was consistent with findings obtained in 	
the study performed by Burstein [8], who investigated sodium fluorescein 

permeability in vivo (dynamic conditions). In their study, 0.01 % BAC also showed no 
significant increase. However, the permeability was increased 1.23-fold by 0.02 % of 
BAC. The effect of 0.02 % BAC was also investigated by Uematsu et al. [47] using an 
in vivo TEER measuring system. A significant decrease in TEER was observed in 
humans at 0.02% BAC but not at 0.01 % BAC. Higher concentrations were not tested 
due to their harmful potential [17]. Furthermore, both studies showed, that both 
investigated rabbit groups were more susceptible to BAC and yielded significant 
results at lower concentrations compared to humans [8,47]. These findings underline 
once more that rabbits cannot reliably predict human physiology and that alternative 	
test systems are needed. 

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Apart from concentration-dependent effects, exposure time-dependent effects have 
also been reported for BAC [18,29,46]. For example, Nakagawa et al. [34] found no 
significant increase in carboxyfluorescein permeability for 0.002 % BAC after 10 min 
exposure, but only after 6 h exposure. These investigations highlight that the results 
are not only dependent on the BAC concentration but also on its exposure time. In 
our experiments, 0.01 % BAC significantly increased the concentration curve under 
static conditions but not under dynamic conditions, as the exposure time was clearly 
shorter and in vivo-like in the dynamic test system. 
Because BAC is rapidly diluted in vivo [16], dynamic test conditions have always 	
been favorable but rarely developed. Nakamura et al. [35] generated a dynamic ex 

vivo test system in which the rabbit cornea is mounted in an Ussing chamber system 	
and the donor compartment is drained by a peristaltic pump. Similar to the previously 	
described studies, the decrease in TEER was higher with increasing BAC 	
concentration. More importantly, the turnover rate was varied to simulate normal or 	
dry eye precorneal physiology, and an increasing harmful potential with decreasing 	
flow rate was observed. These findings were confirmed by our results, as we were 	
able to nearly eliminate the barrier-impairing effect of 0.02 % BAC with an elevated 	
flow rate (10.3-fold vs. 1.6-fold increase of sodium fluorescein concentration). The 	
importance of the chosen flow rate may also explain the relatively high increase in 		
acceptor concentration after dynamic exposure to 0.02 % BAC for the normal flow 	

rate. In our study, the experimental conditions resulted in a 10.3-fold increase. 

However, Burstein only found a 1.23-fold increase in vivo [8]. Taking this study into 

consideration, our elevated flow rate resulted in similar values compared to the in 

vivo conditions, and a better in vivo correlation may be obtained with a slightly higher 

flow rate. In the study of Nakamura et al. [35], a higher tear flow was selected in 

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contrast to our values. However, previous literature reports have described many 

different physiological flow rates which were mostly investigated using very different 

methods [1,12,14,33,43]. Thus, additional research studies are needed to determine 

the optimal conditions to reliably predict in vivo results. Nevertheless, both studies 
	
emphasize, the importance of flow rate selection and moreover highlight the great 


opportunity of controlling the dilution rate, thereby simulating different physiological 
states. 
10 Conclusions 
Overall, the present study showed that adaption of our HC construct to the 
DynaMiTES was feasible and could be successfully performed. Thus, we propose 
that other in vitro models may also be adapted and applied using our novel platform. 
In this way, a future combination of different single DynaMiTES “organs” as proposed 
in our first study (see PART 1) is implementable.  
Furthermore, the first dynamic experiments emphasize that the Ocular DynaMiTES 	
provides novel and improved information: First, the inbuilt electrodes ensure the real-

time assessment of substance barrier interaction. Second, the dynamic donor control 
enables the simulation of physiological conditions, which may even be varied to 
emulate healthy or diseased states. Furthermore, our system also showed that static 
test procedures may be suitable for the evaluation of tissue permeability using Papp, 
but not for reliable formulation testing. The DynaMiTES, with its highly controlled 
dynamic test conditions, showed better correlation with published in vivo data than 
static conditions. Unfortunately, human corneas are invariably needed for 
transplantation and are rarely available for other applications, such as in studies 
using the Ussing chamber system developed by Nakamura et al. For this reason, we 	
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are convinced that our DynaMiTES represents the optimal combination of a 

prevalidated human in vitro model and a highly controlled dynamic modular device. 
With its application in pharmaceutical substance testing, the disadvantages of animal 
tissue-based test systems and static in vitro models may be circumvented. Finally, 
automation, which is highly demanded in routine application, is realizable. The donor 
application has been previously performed using programmable syringe pumps, and 
the sampling points are provided with septa to enable automatic sampling similar to 
HPLC autosamplers. 
Taken together, these advances ease the application in pharmaceutical research and 
development (R&D). Possible and meaningful applications not only include use in 	
drug absorption but also in functional tests of additives, including permeation 

enhancers and colloidal systems, such as micelles, liposomes and nanoparticles. In 
all these areas, dynamic test procedures might generate more reliable findings than 
non-physiological static test conditions. For this reason, the DynaMiTES is an 
important contribution to pharmaceutical substance testing and may reduce the 
prevailing risk of late stage drug failures. 
In addition to the easy adaption of the HC, the concomitant separation of the 
epithelium and stroma will enable a more precise investigation of substance 
absorption than previously feasible with the classic HC. By the PC membrane 
division, it is conceivable that substance accumulation in the two cell compartments 	
can be investigated independently within or after the experiment. In this way, more 

pharmacokinetic information of the drug absorption can be obtained. 
Nevertheless, further improvements of the Ocular DynaMiTES will focus on the 
implementation of online analysis of the acceptor concentration via an inbuilt sensor. 
Unfortunately, online sensors for this use would require high sensitivity. Thus, 
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external analysis must be maintained until sufficient technology becomes available. 
Another technical improvement would be downsizing the compartments to reduce the 
required substance amount. This is specifically desirable in the preclinical phases 
when few drug is assessable. However, effects of substance distribution and 
elimination by tear flow would be more in vivo-like if the volume of the compartments 	
is reduced. 

Considering the cellular aspects, an investigation of different flow profiles may 
enhance the comprehension of ocular drug absorption. Furthermore, dynamic 
cultivation and its effect on the epithelial barrier should be examined. Taken together, 
these technical and cellular improvements may provide a correlation of the in vitro 
results with clinical findings. In summary, the present study underlines the particular 
value of our novel DynaMiTES system and our successful aim to raise the 
prevalidated HC to a new sustainable level in in vitro drug absorption testing.  
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12 Captions 	
Figure 1: Images of the DynaMiTES; A: The assembled DynaMiTES; B: The three 

separate levels (from left to right): top level, insert level and bottom level. 
Figure 2: Depiction of the experimental setup for donor flow or donor dilution 
experiments; sodium fluorescein donor (yellow) was pumped through the 
DynaMiTES by applying different flow rates. The permeated amount was measured 
in the acceptor (light blue). For a clearer overview the incubator is not shown, 
however, all experiments were performed at 37 °C. 
Figure 3: Comparison of classic (left; following [20]) and inverted (right) cultivation; 
light microscopic images show the multilayered epithelium at day 10 of cultivation, 
which was induced by air-liquid interface (ALI). 	
Figure 4: Cell viability assessed by MTT dye reaction of classic hemicorneas, 

inverted hemicorneas and stroma equivalents (without HCE-T cells) at day 10 of 	
cultivation; classic hemicorneas were set to 100 % (mean ± SD.; n = 7-10; 	
** p < 0.01). 	
Figure 5: TEER profiles of classic and inverted hemicorneas from day 6 to day 13 of 	
cultivation; air-liquid interface cultivation from day 7 on is marked by a light-blue 	
frame (mean ± SD; n = 3-8; ** p < 0.01). 	
Figure 6: Comparative permeation study of classic and inverted hemicornea (HC); 	
A: Experimental setup for classic (top) and inverted (bottom) HC with sodium 	
fluorescein donor solution (yellow) and KRB acceptor solution (light blue); yellow 		
arrows mark the direction of sodium fluorescein permeation; B: Resulting apparent 	

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permeation coefficient of sodium fluorescein for classic and inverted HC compared to 

Hahne et al. [20] (mean ± SD; n = 6-7). 

Figure 7: Cell viability determined by MTT dye reaction after 180 min with and without 

flow exposition; the negative control (KRB) was kept in a standard well plate and set 

to 100 %. The samples of 0 µL/min were inserted into the DynaMiTES and the 

system was filled only once (mean ± SD; n = 4-16; ** p < 0.01). 

Figure 8: Relative TEER profiles obtained over the course of 180 min with and 

without flow; the negative control was kept in a standard well plate (0 µL/min well 

plate). The samples for the rate of 0 µL/min were inserted into the DynaMiTES and 
	
the system was filled only once. All groups in the DynaMiTES (except 73 µL/min) are 


significantly different (p < 0.05) to the negative control after 180 min but not to the 
reference in the DynaMiTES (0 µL/min DynaMiTES). For a clearer overview symbols 
for significant differences are not shown (mean ± SD; n = 4-57). 
Figure 9: Permeation coefficient of sodium fluorescein with and without different flow 
rates; 0 µL/min in the well plate served as a negative control and 0.01 % BAC served 
as a positive control (mean ± SD; n = 6-46; ** significantly different to all other 
groups, p < 0.01).  
Figure 10: Acceptor concentration of sodium fluorescein over the course of 180 min; 
A: comparison of common static and innovative dynamic conditions each with and 	
without benzalkonium chloride (BAC) utilizing the DynaMiTES; B: enlarged view of 

the lower permeation profiles of A (mean ± SD; n = 2-6).  
Table 1: Cell morphology of inverted human hemicornea at day 10 of cultivation with 
1 h, 3 h or 18 h (overnight) epithelial cell attachment during fabrication; “hair-like” 
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structures in the epithelium resulted from the known but unavoidable interaction of 
the PC membrane and resin material. 
Table 2: Images of light microscopy (left) and scanning electron microscopy (right) of 
inverted hemicorneas after 180 min with and without flow; the negative control was 
kept in a standard well plate (0 µL/min well plate). The samples of 0 µL/min were 
inserted into the DynaMiTES and the system was filled only once (0 µL/min 	
DynaMiTES). For the positive control, inverted HCs were scratched with a glass 

pipette. The injured area with the visible PC membrane is marked in red.  
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